ClinConnect ClinConnect Logo
Search / Trial NCT06746935

Reconstruction of Deficient Atrophic Ridges Using Guide Bone Regeneration Technique

Launched by CAIRO UNIVERSITY · Dec 18, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Ridge Augmentation Polytetrafluoroethylene Native Collagen Membrane

ClinConnect Summary

This clinical trial is studying a technique called guided bone regeneration to help patients with insufficient bone in their upper jaw, which can be necessary for dental implants. Participants will be divided into two groups: one will receive a mixture of their own bone and a type of animal bone, covered with a special material, while the other group will have the same mixture but covered with a different, dissolvable material. The goal is to see which method works better in helping to rebuild the bone.

To be eligible for this trial, participants should have a certain amount of bone height and width in their jaw, at least one missing tooth, and should not have serious health issues that could affect healing, such as uncontrolled diabetes or a history of certain cancers. If you join the trial, you can expect several steps, including imaging tests before and after the procedure, surgery to collect and mix the bone, and careful follow-up to ensure everything is healing well. This research aims to improve dental procedures for those who need bone augmentation.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with maxillary residual alveolar bone height not less than 8 mm.
  • Alveolar bone width from less than or equal 5 mm.
  • Both sexes.
  • At least missing single tooth.
  • Previous Failed Implants.
  • Previous Failed Grafting.
  • Exclusion Criteria:
  • Heavy smokers more than 20 cigarettes per day.
  • Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
  • Patients had radiotherapy and chemotherapy in head and neck.
  • Patients had neoplasms in sites to be grafted.
  • Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Ahmed M. Youssef, PHD.

Study Director

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cairo University, Egypt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported